Ashley Vanscyoc, NP
Acute Care · Morgantown, WVNPI 1235771163
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.9%), travel and lodging and education — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Boston Scientific at 32.8% of the total. Among acute care clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 346 payments — averaging $46.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$5K
- Edwards Lifesciences$5K
- Medtronic$2K
- Abbott$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$624
- Johnson & Johnson$259
- plus $1K from 18 others
What the payments were for
- Travel & lodging$7,25645%
- Food & beverage$8,63454%
- Education$1311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 68 | $5,251 |
| Edwards Lifesciences | 81 | $4,794 |
| Medtronic | 78 | $2,457 |
| Abbott | 24 | $1,584 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 36 | $624 |
| Johnson & Johnson | 12 | $259 |
| Novartis | 16 | $244 |
| Recor Medical Inc | 4 | $154 |
| Janssen Scientific Affairs, LLC | 1 | $101 |
| Abiomed | 3 | $99 |
| Boehringer Ingelheim | 4 | $68 |
| Amgen | 3 | $65 |
| Heartflow, Inc. | 2 | $64 |
| Philips North America LLC | 2 | $57 |
| E.r. Squibb & Sons, L.L.C. | 2 | $34 |
| Pfizer | 2 | $29 |
| Novo Nordisk | 1 | $24 |
| Merck | 1 | $20 |
| Bayer | 1 | $19 |
| Kestra Medical Technology Services, Inc. | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Siemens Medical Solutions USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$2,401
- Edwards SAPIEN 3 Transcatheter Heart Valve$1,655
- COREVALVE EVOLUT R$1,328
- WATCHMAN FLX$1,117
- MitraClip$944
- SAPIEN 3 Ultra RESILIA$117
- XARELTO$101
- Watchman$101
How this compares
$16,021 in reported general payments places this provider in the 95th percentile of 51 acute care providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $22,919 |
| EntrestoSacubitril/Valsartan | 29 | $21,891 |
| XareltoRivaroxaban | 14 | $21,740 |
| BrilintaTicagrelor | 28 | $19,907 |
| ClopidogrelClopidogrel Bisulfate | 158 | $1,961 |
| Metoprolol Succinate | 62 | $604 |
| Atorvastatin Calcium | 17 | $299 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 18 | $191 |
| Lisinopril | 20 | $185 |
| Carvedilol | 15 | $175 |
| Amlodipine Besylate | 14 | $58 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $29 | $22,91928 claims |
| NovartisEntresto | $244 | $21,89129 claims |
| Johnson & JohnsonXarelto | $259 | $21,74014 claims |
| AstraZenecaBrilinta | $15 | $19,90728 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 51 acute care providers in West Virginia.
Other acute care in Morgantown
- Zachariah RigglemanMorgantown$1K
- Monica ThomasMorgantown$984
- Brenda OverstreetMorgantown$719
- Lindsay HedrickMorgantown$542
- Ashley DavisMorgantown$415
- Sabrina GlosserMorgantown$284
- Donnie GoodwinMorgantown$273
- Kristina ButlerMorgantown$131
- Jamie BoyceMorgantown$118
- Kelly MocciaMorgantown$79
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.